EL Food and Drug Administration he authorized it vaccination with a third booster dose of your vaccine Pfizer and BioNTech per Covid-19 for people over 65 and vulnerable groups. The FDA decision comes after an 8-hour meeting of the Agency the previous days, where a group of external experts discussed and voted on the implementation of the Pfizer vaccine to offer potential doses to the general public.
EL Advisory Committee on Vaccines and Related Organic Products voted against 16-2 against the distribution of vaccines to Americans 16 years of age or older before unanimously adopting one alternative plan for third terms in older Americans and in those at high risk for serious illness if they are infected with the coronavirus.
Today we have modified the emergency use authorization (USA) for the Pfizer-BioNTech COVID-19 vaccine to allow the use of a single booster dose, which must be administered at least 6 months after the completion of the primary vaccine series in certain populations. https://t.co/xF8h0kmF61 pic.twitter.com/3dsIhM9MoV
– US FDA (@US_FDA) September 22, 2021
The Biden government had said in recent days that it wanted to start offering boosts to the general public as early as this week, pending permission from regulators. USA.
In documents released last week, Pfizer cited an observational study in Israel that showed that a third dose of the Covid-19 vaccine six months after the second dose restored 95% protection against infection. Data were collected from July 1 to August 30, at which time the information quickly spread. Delta mutation increased nationwide.
Greece and the US are strong allies in the fight against illicit trafficking in cultural goods
Check out all the latest news from Greece and the world, as they happen, at Protothema.gr